600196.SHG Shanghai Fosun Pharmaceutical Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
29.70 CNY
Close of Nov 4, 2026
20.85 29.13
Market cap
CNY 62.9B
P/E
17.5x
P/B
1.22x
ROE
7.1%
Dividend yield
1.34%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600196.SHG undervalued?

Graham number
Price29.70
Graham value30.51
Discount2.7%

600196.SHG trades 2.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Fosun Pharmaceutical Group Co Ltd fundamental analysis

No fundamental analysis for Shanghai Fosun Pharmaceutical Group Co Ltd yet.

Shanghai Fosun Pharmaceutical Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabo…

Full company profile